Last reviewed · How we verify
Remdesivir-HU
Remdesivir-HU is an antiviral medication that works by inhibiting viral RNA-dependent RNA polymerase.
Remdesivir-HU is an antiviral medication that works by inhibiting viral RNA-dependent RNA polymerase. Used for COVID-19.
At a glance
| Generic name | Remdesivir-HU |
|---|---|
| Sponsor | University of Pecs |
| Drug class | Nucleoside analog |
| Target | RNA-dependent RNA polymerase |
| Modality | Small molecule |
| Therapeutic area | Infectious Diseases |
| Phase | Phase 3 |
Mechanism of action
Remdesivir-HU is a nucleoside analog that is incorporated into the viral RNA, causing chain termination and thus inhibiting viral replication. This mechanism of action is effective against a wide range of RNA viruses, including SARS-CoV-2.
Approved indications
- COVID-19
Common side effects
- Nausea
- Vomiting
- Diarrhea
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |